- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Senores Pharma will acquire 100% of Apnar Pharma for ~Rs. 91 Cr (including debt). Apnar is a generic drug manufacturer with US FDA-approved facilities. This strategic acquisition enhances Senores' manufacturing capabilities and market presence.